Endocannabinoid involvement in beneficial effects of caloric restriction in a rodent model of comorbid depression and epilepsy

Clinically, patients with depression are at a heightened risk for developing epilepsy, and vice versa, suggesting shared mechanisms for this bidirectional comorbidity. Unfortunately, comorbid depression and epilepsy is associated with worsened quality of life and treatment refractoriness, highlighti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Progress in neuro-psychopharmacology & biological psychiatry 2024-12, Vol.136, p.111212, Article 111212
Hauptverfasser: Allemeier, Ashley M., Drummond, Christine, Tiefenthaler, Bradley, Dvorak, Tierney C., Holz, Faith N., Hume, Catherine, Kreger, Rachelle B., Koulibali, Chauncella I., Khan, Humza A., Best, Alexa L., Gee, Timothy, Pedersen, Grace D., Glover, Kevin, Ganu, Dollar, Martin, Julie, Hill, Matthew N., Epps, S. Alisha
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 111212
container_title Progress in neuro-psychopharmacology & biological psychiatry
container_volume 136
creator Allemeier, Ashley M.
Drummond, Christine
Tiefenthaler, Bradley
Dvorak, Tierney C.
Holz, Faith N.
Hume, Catherine
Kreger, Rachelle B.
Koulibali, Chauncella I.
Khan, Humza A.
Best, Alexa L.
Gee, Timothy
Pedersen, Grace D.
Glover, Kevin
Ganu, Dollar
Martin, Julie
Hill, Matthew N.
Epps, S. Alisha
description Clinically, patients with depression are at a heightened risk for developing epilepsy, and vice versa, suggesting shared mechanisms for this bidirectional comorbidity. Unfortunately, comorbid depression and epilepsy is associated with worsened quality of life and treatment refractoriness, highlighting the need for novel treatment targets and nonpharmacologic supplements to existing therapies. The present study used the Swim-Low Active rat, a well-validated model of depression and epilepsy comorbidity that was selectively bred based on forced swim test behavior, to assess the safety and efficacy of caloric restriction in treating this comorbidity. The study also investigated the role of endocannabinoids in the effects of caloric restriction on the behavioral endpoints and to determine whether there were any sex differences in these effects. Male rats restricted to approximately 80 % of their daily food intake for an acute 24-h period showed elevated struggling behavior in the Porsolt (Forced) Swim Test and increased latency to pilocarpine-induced seizure; this same caloric restriction yielded a significant increase in hippocampal anandamide levels compared to ad lib rats. These effects were not seen in female rats, although female rats did show anticonvulsant effects of chronic caloric restriction. Administration of 1 mg/kg SR141716 alongside an acute caloric restriction in male rats blocked the antidepressant-like effects of caloric restriction but did not affect seizure responses. Combined, these results suggest caloric restriction may be both safe and modestly effective in benefitting depression- and epilepsy-related behaviors in male SwLo rats, and that the endocannabinoid system may be a promising target for treating this comorbidity. •SwLo rats are a model of depression and epilepsy comorbidity.•Acute caloric restriction boosts forced swim struggle in male SwLo, but not female.•Acute caloric restriction increases onset to seizure in male, but not female, SwLo.•These effects are modulated at least in part by anandamide and CB1 signaling.•Caloric restriction affects depression and epilepsy in sexually dimorphic ways.
doi_str_mv 10.1016/j.pnpbp.2024.111212
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3146569625</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S027858462400280X</els_id><sourcerecordid>3146569625</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1540-a472619054c0c65700b84f19a2d7e72841f8239428f14d58cf7af67a8fe6d6ad3</originalsourceid><addsrcrecordid>eNp9kD2PGyEQhlGUU-xz8gsinbZMY4dhWZYtUkTWfUmW0lxqxMIgYe3CHtiW3OS3hz07Ka96p3jeGXgI-Qp0AxTE9_1mClM_bRhlfAMADNgHsgTZyjVnID6SJWVlbiQXC3Kb855SCjWtP5FF3QnegKRL8uc-2Gh0CLr3IXpb-XCKwwlHDIcyVz0GdN54PVToHJpDrqKrjB5i8qZKmA8lDz6GGdZVinYujiWGNzCOMfVlrcWpwHkGdbAVTn7AKZ8_kxunh4xfrrkivx_uX7ZP692vx-ftz93aQMPpWvOWCehoww01omkp7SV30GlmW2yZ5OAkqzvOpANuG2lcq51otXQorNC2XpFvl71Tiq_H8mo1-mxwGHTAeMyqBi4a0QnWFLS-oCbFnBM6NSU_6nRWQNUsXu3Vm3g1i1cX8aV1dz1w7Ee0_zv_TBfgxwXA8s2Tx6Sy8RgMWp-KVmWjf_fAX07PltA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3146569625</pqid></control><display><type>article</type><title>Endocannabinoid involvement in beneficial effects of caloric restriction in a rodent model of comorbid depression and epilepsy</title><source>Elsevier ScienceDirect Journals</source><creator>Allemeier, Ashley M. ; Drummond, Christine ; Tiefenthaler, Bradley ; Dvorak, Tierney C. ; Holz, Faith N. ; Hume, Catherine ; Kreger, Rachelle B. ; Koulibali, Chauncella I. ; Khan, Humza A. ; Best, Alexa L. ; Gee, Timothy ; Pedersen, Grace D. ; Glover, Kevin ; Ganu, Dollar ; Martin, Julie ; Hill, Matthew N. ; Epps, S. Alisha</creator><creatorcontrib>Allemeier, Ashley M. ; Drummond, Christine ; Tiefenthaler, Bradley ; Dvorak, Tierney C. ; Holz, Faith N. ; Hume, Catherine ; Kreger, Rachelle B. ; Koulibali, Chauncella I. ; Khan, Humza A. ; Best, Alexa L. ; Gee, Timothy ; Pedersen, Grace D. ; Glover, Kevin ; Ganu, Dollar ; Martin, Julie ; Hill, Matthew N. ; Epps, S. Alisha</creatorcontrib><description>Clinically, patients with depression are at a heightened risk for developing epilepsy, and vice versa, suggesting shared mechanisms for this bidirectional comorbidity. Unfortunately, comorbid depression and epilepsy is associated with worsened quality of life and treatment refractoriness, highlighting the need for novel treatment targets and nonpharmacologic supplements to existing therapies. The present study used the Swim-Low Active rat, a well-validated model of depression and epilepsy comorbidity that was selectively bred based on forced swim test behavior, to assess the safety and efficacy of caloric restriction in treating this comorbidity. The study also investigated the role of endocannabinoids in the effects of caloric restriction on the behavioral endpoints and to determine whether there were any sex differences in these effects. Male rats restricted to approximately 80 % of their daily food intake for an acute 24-h period showed elevated struggling behavior in the Porsolt (Forced) Swim Test and increased latency to pilocarpine-induced seizure; this same caloric restriction yielded a significant increase in hippocampal anandamide levels compared to ad lib rats. These effects were not seen in female rats, although female rats did show anticonvulsant effects of chronic caloric restriction. Administration of 1 mg/kg SR141716 alongside an acute caloric restriction in male rats blocked the antidepressant-like effects of caloric restriction but did not affect seizure responses. Combined, these results suggest caloric restriction may be both safe and modestly effective in benefitting depression- and epilepsy-related behaviors in male SwLo rats, and that the endocannabinoid system may be a promising target for treating this comorbidity. •SwLo rats are a model of depression and epilepsy comorbidity.•Acute caloric restriction boosts forced swim struggle in male SwLo, but not female.•Acute caloric restriction increases onset to seizure in male, but not female, SwLo.•These effects are modulated at least in part by anandamide and CB1 signaling.•Caloric restriction affects depression and epilepsy in sexually dimorphic ways.</description><identifier>ISSN: 0278-5846</identifier><identifier>ISSN: 1878-4216</identifier><identifier>EISSN: 1878-4216</identifier><identifier>DOI: 10.1016/j.pnpbp.2024.111212</identifier><identifier>PMID: 39645180</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Anandamide ; Caloric restriction ; Comorbidity ; Depression ; Diet ; Endocannabinoid ; Epilepsy</subject><ispartof>Progress in neuro-psychopharmacology &amp; biological psychiatry, 2024-12, Vol.136, p.111212, Article 111212</ispartof><rights>2024 Elsevier Inc.</rights><rights>Copyright © 2024 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1540-a472619054c0c65700b84f19a2d7e72841f8239428f14d58cf7af67a8fe6d6ad3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S027858462400280X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39645180$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Allemeier, Ashley M.</creatorcontrib><creatorcontrib>Drummond, Christine</creatorcontrib><creatorcontrib>Tiefenthaler, Bradley</creatorcontrib><creatorcontrib>Dvorak, Tierney C.</creatorcontrib><creatorcontrib>Holz, Faith N.</creatorcontrib><creatorcontrib>Hume, Catherine</creatorcontrib><creatorcontrib>Kreger, Rachelle B.</creatorcontrib><creatorcontrib>Koulibali, Chauncella I.</creatorcontrib><creatorcontrib>Khan, Humza A.</creatorcontrib><creatorcontrib>Best, Alexa L.</creatorcontrib><creatorcontrib>Gee, Timothy</creatorcontrib><creatorcontrib>Pedersen, Grace D.</creatorcontrib><creatorcontrib>Glover, Kevin</creatorcontrib><creatorcontrib>Ganu, Dollar</creatorcontrib><creatorcontrib>Martin, Julie</creatorcontrib><creatorcontrib>Hill, Matthew N.</creatorcontrib><creatorcontrib>Epps, S. Alisha</creatorcontrib><title>Endocannabinoid involvement in beneficial effects of caloric restriction in a rodent model of comorbid depression and epilepsy</title><title>Progress in neuro-psychopharmacology &amp; biological psychiatry</title><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><description>Clinically, patients with depression are at a heightened risk for developing epilepsy, and vice versa, suggesting shared mechanisms for this bidirectional comorbidity. Unfortunately, comorbid depression and epilepsy is associated with worsened quality of life and treatment refractoriness, highlighting the need for novel treatment targets and nonpharmacologic supplements to existing therapies. The present study used the Swim-Low Active rat, a well-validated model of depression and epilepsy comorbidity that was selectively bred based on forced swim test behavior, to assess the safety and efficacy of caloric restriction in treating this comorbidity. The study also investigated the role of endocannabinoids in the effects of caloric restriction on the behavioral endpoints and to determine whether there were any sex differences in these effects. Male rats restricted to approximately 80 % of their daily food intake for an acute 24-h period showed elevated struggling behavior in the Porsolt (Forced) Swim Test and increased latency to pilocarpine-induced seizure; this same caloric restriction yielded a significant increase in hippocampal anandamide levels compared to ad lib rats. These effects were not seen in female rats, although female rats did show anticonvulsant effects of chronic caloric restriction. Administration of 1 mg/kg SR141716 alongside an acute caloric restriction in male rats blocked the antidepressant-like effects of caloric restriction but did not affect seizure responses. Combined, these results suggest caloric restriction may be both safe and modestly effective in benefitting depression- and epilepsy-related behaviors in male SwLo rats, and that the endocannabinoid system may be a promising target for treating this comorbidity. •SwLo rats are a model of depression and epilepsy comorbidity.•Acute caloric restriction boosts forced swim struggle in male SwLo, but not female.•Acute caloric restriction increases onset to seizure in male, but not female, SwLo.•These effects are modulated at least in part by anandamide and CB1 signaling.•Caloric restriction affects depression and epilepsy in sexually dimorphic ways.</description><subject>Anandamide</subject><subject>Caloric restriction</subject><subject>Comorbidity</subject><subject>Depression</subject><subject>Diet</subject><subject>Endocannabinoid</subject><subject>Epilepsy</subject><issn>0278-5846</issn><issn>1878-4216</issn><issn>1878-4216</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kD2PGyEQhlGUU-xz8gsinbZMY4dhWZYtUkTWfUmW0lxqxMIgYe3CHtiW3OS3hz07Ka96p3jeGXgI-Qp0AxTE9_1mClM_bRhlfAMADNgHsgTZyjVnID6SJWVlbiQXC3Kb855SCjWtP5FF3QnegKRL8uc-2Gh0CLr3IXpb-XCKwwlHDIcyVz0GdN54PVToHJpDrqKrjB5i8qZKmA8lDz6GGdZVinYujiWGNzCOMfVlrcWpwHkGdbAVTn7AKZ8_kxunh4xfrrkivx_uX7ZP692vx-ftz93aQMPpWvOWCehoww01omkp7SV30GlmW2yZ5OAkqzvOpANuG2lcq51otXQorNC2XpFvl71Tiq_H8mo1-mxwGHTAeMyqBi4a0QnWFLS-oCbFnBM6NSU_6nRWQNUsXu3Vm3g1i1cX8aV1dz1w7Ee0_zv_TBfgxwXA8s2Tx6Sy8RgMWp-KVmWjf_fAX07PltA</recordid><startdate>20241205</startdate><enddate>20241205</enddate><creator>Allemeier, Ashley M.</creator><creator>Drummond, Christine</creator><creator>Tiefenthaler, Bradley</creator><creator>Dvorak, Tierney C.</creator><creator>Holz, Faith N.</creator><creator>Hume, Catherine</creator><creator>Kreger, Rachelle B.</creator><creator>Koulibali, Chauncella I.</creator><creator>Khan, Humza A.</creator><creator>Best, Alexa L.</creator><creator>Gee, Timothy</creator><creator>Pedersen, Grace D.</creator><creator>Glover, Kevin</creator><creator>Ganu, Dollar</creator><creator>Martin, Julie</creator><creator>Hill, Matthew N.</creator><creator>Epps, S. Alisha</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20241205</creationdate><title>Endocannabinoid involvement in beneficial effects of caloric restriction in a rodent model of comorbid depression and epilepsy</title><author>Allemeier, Ashley M. ; Drummond, Christine ; Tiefenthaler, Bradley ; Dvorak, Tierney C. ; Holz, Faith N. ; Hume, Catherine ; Kreger, Rachelle B. ; Koulibali, Chauncella I. ; Khan, Humza A. ; Best, Alexa L. ; Gee, Timothy ; Pedersen, Grace D. ; Glover, Kevin ; Ganu, Dollar ; Martin, Julie ; Hill, Matthew N. ; Epps, S. Alisha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1540-a472619054c0c65700b84f19a2d7e72841f8239428f14d58cf7af67a8fe6d6ad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Anandamide</topic><topic>Caloric restriction</topic><topic>Comorbidity</topic><topic>Depression</topic><topic>Diet</topic><topic>Endocannabinoid</topic><topic>Epilepsy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Allemeier, Ashley M.</creatorcontrib><creatorcontrib>Drummond, Christine</creatorcontrib><creatorcontrib>Tiefenthaler, Bradley</creatorcontrib><creatorcontrib>Dvorak, Tierney C.</creatorcontrib><creatorcontrib>Holz, Faith N.</creatorcontrib><creatorcontrib>Hume, Catherine</creatorcontrib><creatorcontrib>Kreger, Rachelle B.</creatorcontrib><creatorcontrib>Koulibali, Chauncella I.</creatorcontrib><creatorcontrib>Khan, Humza A.</creatorcontrib><creatorcontrib>Best, Alexa L.</creatorcontrib><creatorcontrib>Gee, Timothy</creatorcontrib><creatorcontrib>Pedersen, Grace D.</creatorcontrib><creatorcontrib>Glover, Kevin</creatorcontrib><creatorcontrib>Ganu, Dollar</creatorcontrib><creatorcontrib>Martin, Julie</creatorcontrib><creatorcontrib>Hill, Matthew N.</creatorcontrib><creatorcontrib>Epps, S. Alisha</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Progress in neuro-psychopharmacology &amp; biological psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Allemeier, Ashley M.</au><au>Drummond, Christine</au><au>Tiefenthaler, Bradley</au><au>Dvorak, Tierney C.</au><au>Holz, Faith N.</au><au>Hume, Catherine</au><au>Kreger, Rachelle B.</au><au>Koulibali, Chauncella I.</au><au>Khan, Humza A.</au><au>Best, Alexa L.</au><au>Gee, Timothy</au><au>Pedersen, Grace D.</au><au>Glover, Kevin</au><au>Ganu, Dollar</au><au>Martin, Julie</au><au>Hill, Matthew N.</au><au>Epps, S. Alisha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Endocannabinoid involvement in beneficial effects of caloric restriction in a rodent model of comorbid depression and epilepsy</atitle><jtitle>Progress in neuro-psychopharmacology &amp; biological psychiatry</jtitle><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><date>2024-12-05</date><risdate>2024</risdate><volume>136</volume><spage>111212</spage><pages>111212-</pages><artnum>111212</artnum><issn>0278-5846</issn><issn>1878-4216</issn><eissn>1878-4216</eissn><abstract>Clinically, patients with depression are at a heightened risk for developing epilepsy, and vice versa, suggesting shared mechanisms for this bidirectional comorbidity. Unfortunately, comorbid depression and epilepsy is associated with worsened quality of life and treatment refractoriness, highlighting the need for novel treatment targets and nonpharmacologic supplements to existing therapies. The present study used the Swim-Low Active rat, a well-validated model of depression and epilepsy comorbidity that was selectively bred based on forced swim test behavior, to assess the safety and efficacy of caloric restriction in treating this comorbidity. The study also investigated the role of endocannabinoids in the effects of caloric restriction on the behavioral endpoints and to determine whether there were any sex differences in these effects. Male rats restricted to approximately 80 % of their daily food intake for an acute 24-h period showed elevated struggling behavior in the Porsolt (Forced) Swim Test and increased latency to pilocarpine-induced seizure; this same caloric restriction yielded a significant increase in hippocampal anandamide levels compared to ad lib rats. These effects were not seen in female rats, although female rats did show anticonvulsant effects of chronic caloric restriction. Administration of 1 mg/kg SR141716 alongside an acute caloric restriction in male rats blocked the antidepressant-like effects of caloric restriction but did not affect seizure responses. Combined, these results suggest caloric restriction may be both safe and modestly effective in benefitting depression- and epilepsy-related behaviors in male SwLo rats, and that the endocannabinoid system may be a promising target for treating this comorbidity. •SwLo rats are a model of depression and epilepsy comorbidity.•Acute caloric restriction boosts forced swim struggle in male SwLo, but not female.•Acute caloric restriction increases onset to seizure in male, but not female, SwLo.•These effects are modulated at least in part by anandamide and CB1 signaling.•Caloric restriction affects depression and epilepsy in sexually dimorphic ways.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>39645180</pmid><doi>10.1016/j.pnpbp.2024.111212</doi></addata></record>
fulltext fulltext
identifier ISSN: 0278-5846
ispartof Progress in neuro-psychopharmacology & biological psychiatry, 2024-12, Vol.136, p.111212, Article 111212
issn 0278-5846
1878-4216
1878-4216
language eng
recordid cdi_proquest_miscellaneous_3146569625
source Elsevier ScienceDirect Journals
subjects Anandamide
Caloric restriction
Comorbidity
Depression
Diet
Endocannabinoid
Epilepsy
title Endocannabinoid involvement in beneficial effects of caloric restriction in a rodent model of comorbid depression and epilepsy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T04%3A01%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Endocannabinoid%20involvement%20in%20beneficial%20effects%20of%20caloric%20restriction%20in%20a%20rodent%20model%20of%20comorbid%20depression%20and%20epilepsy&rft.jtitle=Progress%20in%20neuro-psychopharmacology%20&%20biological%20psychiatry&rft.au=Allemeier,%20Ashley%20M.&rft.date=2024-12-05&rft.volume=136&rft.spage=111212&rft.pages=111212-&rft.artnum=111212&rft.issn=0278-5846&rft.eissn=1878-4216&rft_id=info:doi/10.1016/j.pnpbp.2024.111212&rft_dat=%3Cproquest_cross%3E3146569625%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3146569625&rft_id=info:pmid/39645180&rft_els_id=S027858462400280X&rfr_iscdi=true